PERHA PHARMACEUTICALS
Perha Pharmaceuticals is a bio technology company which does research & development of kinase inhibitors.
PERHA PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Roscoff, Bretagne, France
Country:
France
Website Url:
http://www.perha-pharma.fr
Total Employee:
11+
Status:
Active
Contact:
0608605834
Total Funding:
3.1 M EUR
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Employees Featured
Founder
Investors List
Fondation Jerome Lejeune
Fondation Jerome Lejeune investment in Seed Round - Perha Pharmaceuticals
Bpifrance
Bpifrance investment in Debt Financing - Perha Pharmaceuticals
Official Site Inspections
http://www.perha-pharma.fr
- Host name: ns319676.ip-5-135-139.eu
- IP address: 5.135.139.120
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Perha Pharmaceuticals"
perha-pharma.fr – Perha Pharmaceuticals
Perha Pharmaceuticals « From Sea to Pharmacy » Perha Pharmaceuticals est une société de biotechnologies spécialisée dans la recherche et le développement d’inhibiteurs de kinases, auxquels le Dr Meijer, Directeur …See details»
A propos – perha-pharma.fr
Perha Pharmaceuticals - LinkedIn
Perha Pharmaceuticals is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors and developing them up to proof-of-concept in man.See details»
Perha Pharmaceuticals - Org Chart, Teams, Culture & Jobs | The Org
View Perha Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Perha Pharmaceuticals - Crunchbase Company Profile & Funding
Perha Pharmaceuticals is a biotechnology company that specializes in the research and development of kinase inhibitors. The company's investigation begins with natural marine …See details»
Perha Pharmaceuticals Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Perha Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
perha-pharma.com – Perha Pharmaceuticals
Preclinical products Perha Pharmaceuticals focuses on two innovative preclinical programs : correction of cognitive deficits associated with Down syndrome and Alzheimer’s disease and prevention of hearing loss induced by ototoxic drugs.See details»
Cette société développe un médicament pour faciliter …
Aug 30, 2023 À Roscoff, près de Morlaix (Finistère), Perha Pharmaceuticals travaille sur le développement d’un médicament qui pourrait faciliter la vie des personnes atteintes de trisomie 21. Comment ...See details»
About Perha Pharmaceuticals - Atlanpole Biotherapies
Sep 15, 2022 Perha Pharmaceuticals is a drug discovery and early development platform based on a deep expertise in protein kinases and their pharmacological inhibitors. The Start-up aims …See details»
PERHA PHARMACEUTICALS - Atlanpole Biotherapies
ManRos Therapeutics is a biotechnology start-up whose creation relies on pharmacological inhibitors of protein kinases developed by the CNRS unit previously headed by Laurent …See details»
PERHA PHARMACEUTICALS ACCÉLÈRE SON APPRENTISSAGE …
Sep 2, 2022 Perha fait précisément le pari inverse à l’instar d’une autre biotech française, Aelis Pharma, qui a réalisé cette année son entrée sur le marché boursier (capitalisation 129 M€). …See details»
Projets – perha-pharma.fr
Projets en développement Perha Pharmaceuticals se concentre sur deux indications thérapeutiques : la correction des déficits cognitifs associés à la trisomie 21, et la prévention …See details»
Sponsors – perha-pharma.com
The Jérôme Lejeune Foundation supports Perha Pharmaceuticals’ Cognitive deficits program and contributes to financing the optimization and preclinical development of the LCTB-21 drug …See details»
Un candidat médicament entre dans la phase décisive des essais ...
Nov 12, 2020 Première étape franchie avec succès pour la molécule phare du laboratoire Perha Pharmaceuticals, dans la course au médicament correcteur du déficit intellectuel des …See details»
Perha Pharmaceuticals retenue par Capital Cell, la seule plateforme ...
Mar 4, 2024 Des négociations et accords sont en cours avec des fondations, gestionnaires de fortunes, etc. Parmi les démarches actuelles, Perha Pharmaceuticals vient d’être retenue par …See details»
L’actualite de Perha Pharmaceuticals – perha-pharma.fr
L’actualite de Perha Pharmaceuticals Retrouvez l’actualité relative à Perha Pharmaceuticals, ainsi que des dossiers liés aux programmes de développement.See details»
Perha Pharmaceuticals - EU-Startups
Perha Pharmaceuticals is a biotechnology company that does research & development of kinase inhibitors. Perha Pharma focuses its research on two main diseases: cognitive disorders …See details»
Perha Pharmaceuticals raises €3.1M - French Healthcare
Dec 21, 2021 Perha Pharmaceuticals raises €3.1M As a result of this round of financing, the biotech company is refining the selection of its drug candidate for the correction of cognitive …See details»
Science – perha-pharma.fr
Science Perha Pharmaceuticals se consacre au développement d’inhibiteurs de protéines kinases impliquées dans diverses pathologies humaines. Dans le cas des déficits cognitifs associés à …See details»
Perha Pharmaceuticals lève de nouveaux fonds pour un espoir ...
Nov 13, 2024 A Roscoff, Perha Pharmaceuticals avance dans le développement de la Leucettinib-21, une petite molécule inhibitrice de la protéine kinase DYRK1A, qui cible les …See details»